Literature DB >> 1629063

Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients.

C Cahan1, M J Decker, J L Arnold, L H Washington, J D Veldhuis, E Goldwasser, K P Strohl.   

Abstract

We measured arterial oxygen saturation (SaO2) and serum erythropoietin (EPO) levels in patients with obstructive sleep apnea syndrome (OSAS) and in healthy subjects. SaO2 profile was analyzed as the cumulative distribution of SaO2 over time. OSAS patients spent 25.5 +/- 30.9% (SD) of the time at SaO2 of less than 88% vs. 0.64 +/- 1.6% in healthy subjects (P less than 0.05) and had 59 +/- 25 desaturations (greater than 4%) per hour vs. less than 5 per hour in healthy subjects (P less than 0.05). EPO measurements (radioimmunoassay) were made in blood samples withdrawn every 1 or 2 h over a 24-h period. The mean EPO concentration was higher (P less than 0.05) for OSAS patients (45 +/- 33 mU/ml) than for normal subjects (17 +/- 8 mU/ml). There was a significant variability in EPO values over the 24-h period. To analyze the EPO pattern over 24 h, EPO time series were fit to a general cosine function. Data from normal subjects conformed to a cosine function with an amplitude of 3.5 +/- 2.1 (CV of 60%) and an acrophase of 1,000 +/- 184 min after 0800 (CV of 18%), indicating a zenith about 1 A.M. and a nadir around 1 P.M. Data from OSAS subjects fit a similar cosine function with an amplitude of 19.9 +/- 41.0 (CV of 206%) and acrophase of 582 +/- 408 min (CV of 70%), indicating a greater variability in the magnitude and the timing of peak serum EPO levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629063     DOI: 10.1152/jappl.1992.72.6.2112

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  16 in total

1.  Determining an erythropoietin threshold is not sufficient for accelerating erythrocyte production by Julien V. Brugniaux, Aurélien Pichon.

Authors:  Gustave Savourey; Pietro E di Prampero
Journal:  Eur J Appl Physiol       Date:  2006-12-13       Impact factor: 3.078

2.  Determining an erythropoietin threshold is not sufficient for accelerating erythrocyte production.

Authors:  Julien Brugniaux; Aurélien Pichon
Journal:  Eur J Appl Physiol       Date:  2006-12-13       Impact factor: 3.078

Review 3.  Reticulocytes in sports medicine.

Authors:  Giuseppe Banfi
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

4.  Does obstructive sleep apnea increase hematocrit?

Authors:  Jong Bae Choi; José S Loredo; Daniel Norman; Paul J Mills; Sonia Ancoli-Israel; Michael G Ziegler; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

5.  An early effect of acute plasma volume expansion in humans on serum erythropoietin concentration.

Authors:  Z Szyguła; J Smitz; J Roeykens; K De Meirleir; T Klausen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

6.  Diurnal variations of serum erythropoietin at sea level and altitude.

Authors:  T Klausen; T D Poulsen; N Fogh-Andersen; J P Richalet; O J Nielsen; N V Olsen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

7.  The effect of short and long duration exercise on serum erythropoietin concentrations.

Authors:  T Klausen; L Breum; N Fogh-Andersen; P Bennett; E Hippe
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

8.  Increased erythropoietin concentration after repeated apneas in humans.

Authors:  Robert de Bruijn; Matt Richardson; Erika Schagatay
Journal:  Eur J Appl Physiol       Date:  2007-12-19       Impact factor: 3.078

Review 9.  Iron and anemia in human biology: a review of mechanisms.

Authors:  Garry J Handelman; Nathan W Levin
Journal:  Heart Fail Rev       Date:  2008-03-25       Impact factor: 4.214

10.  Pharmacokinetic and Pharmacodynamic Comparison of Two Recombinant Human Erythropoietin Formulations, PDA10 and Eprex, in Healthy Korean Male Volunteers: A Randomized, Double-Blinded, Single-Dose, Two-Period Crossover Study.

Authors:  MinKyung Oh; Jaeseung Yoon; Doo-Yeoun Cho
Journal:  Clin Drug Investig       Date:  2015-10       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.